Literature DB >> 20303207

Oral function after oncological intervention in the oral cavity: a retrospective study.

Caroline M Speksnijder1, Hilbert W van der Glas, Andries van der Bilt, Robert J J van Es, Esther van der Rijt, Ron Koole.   

Abstract

PURPOSE: To assess self-perceived oral function of patients with oral cavity cancer at different stages of treatment, ie, before oncologic intervention, 5 weeks after intervention, and 5 years after intervention. PATIENTS AND METHODS: A cohort of 158 patients with malignancy in the oral cavity treated by surgery in 1999 or 2000 was included. From this cohort we interviewed 69 patients by telephone in 2005 and collected data on dental status, disorders of chewing and swallowing, xerostomia, preference of food consistency, tube nutrition, weight loss, and speech for different stages of treatment.
RESULTS: For patients treated in the maxilla region we observed a significant (P < .05) recovery of perceived chewing ability after 5 years to the level experienced before oncologic intervention. Patients treated in the mandible region reported a deteriorated dental state, chewing ability, lip competence, and xerostomia after 5 years. Patients treated in the tongue and mouth-floor region experienced deterioration for dental state, chewing ability, and xerostomia after 5 years compared with the level before the oncologic intervention.
CONCLUSIONS: Our telephone interview on oral function provided supplementary information on how patients experienced their problems with oral function during various phases of oncologic treatment. A retrospective interview may thus help to add information to incomplete retrospective data. 2010 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20303207     DOI: 10.1016/j.joms.2009.09.016

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  9 in total

1.  Radiation Therapy Reduced Blood Levels of LDH, HIF-1α, and miR-210 in OSCC.

Authors:  Marcela Gonçalves de Souza; Sabrina Ferreira de Jesus; Eloá Mangabeira Santos; Emisael Stenio Batista Gomes; Arlen de Paulo Santiago Filho; Eliane Macedo Sobrinho Santos; Luiz Henrique da Silveira; Sérgio Henrique Sousa Santos; Alfredo Maurício Batista de Paula; Lucyana Conceição Farias; André Luiz Sena Guimarães
Journal:  Pathol Oncol Res       Date:  2018-11-08       Impact factor: 3.201

2.  Treatment of mucositis with combined 660- and 808-nm-wavelength low-level laser therapy reduced mucositis grade, pain, and use of analgesics: a parallel, single-blind, two-arm controlled study.

Authors:  Raquel Gusmão Soares; Lucyana Conceição Farias; Agna Soares da Silva Menezes; Carla Silvana de Oliveira E Silva; Angeliny Tamiarana Lima Tabosa; Pablo Vinicyus Ferreira Chagas; Laís Santiago; Sérgio Henrique Sousa Santos; Alfredo Maurício Batista de Paula; André Luiz Sena Guimarães
Journal:  Lasers Med Sci       Date:  2018-06-15       Impact factor: 3.161

Review 3.  The life experience of nutrition impact symptoms during treatment for head and neck cancer patients: a systematic review and meta-synthesis.

Authors:  Valentina Bressan; Annamaria Bagnasco; Giuseppe Aleo; Gianluca Catania; Milko P Zanini; Fiona Timmins; Loredana Sasso
Journal:  Support Care Cancer       Date:  2017-02-15       Impact factor: 3.603

4.  Oral cancer malnutrition impacts weight and quality of life.

Authors:  Nils-Claudius Gellrich; Jörg Handschel; Henrik Holtmann; Gertrud Krüskemper
Journal:  Nutrients       Date:  2015-03-27       Impact factor: 5.717

5.  Assessment of swallowing and masticatory performance in obturator wearers: a clinical study.

Authors:  Nungotso Vero; Niraj Mishra; Balendra Pratap Singh; Kamleshwar Singh; Sunit Kumar Jurel; Vijay Kumar
Journal:  J Adv Prosthodont       Date:  2015-02-17       Impact factor: 1.904

6.  Reliability and validity of measuring scale for postoperative complications in third molar surgery.

Authors:  Pedro Christian Aravena; Paula Astudillo; Horacio Miranda; Carlos Manterola
Journal:  BMC Oral Health       Date:  2018-02-21       Impact factor: 2.757

7.  Metformin increases PDH and suppresses HIF-1α under hypoxic conditions and induces cell death in oral squamous cell carcinoma.

Authors:  Talita Antunes Guimarães; Lucyana Conceição Farias; Eliane Sobrinho Santos; Carlos Alberto de Carvalho Fraga; Lissur Azevedo Orsini; Leandro de Freitas Teles; John David Feltenberger; Sabrin Ferreira de Jesus; Marcela Gonçalves de Souza; Sérgio Henrique Sousa Santos; Alfredo Maurício Batista de Paula; Ricardo Santiago Gomez; André Luiz Sena Guimarães
Journal:  Oncotarget       Date:  2016-08-23

8.  Masticatory function and related factors after oral oncological treatment: A 5-year prospective study.

Authors:  Reilly J de Groot; Jan-Willem Wetzels; Matthias A W Merkx; Antoine J W P Rosenberg; Anton F J de Haan; Andries van der Bilt; Jan H Abbink; Caroline M Speksnijder
Journal:  Head Neck       Date:  2018-12-15       Impact factor: 3.147

9.  Depression and related factors after oral oncological treatment: a 5-year prospective cohort study.

Authors:  Caroline M Speksnijder; Petra J M Lankhorst; Remco de Bree; Anton F J de Haan; Ron Koole; Matthias A W Merkx
Journal:  Support Care Cancer       Date:  2020-10-01       Impact factor: 3.603

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.